Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coagulation Activation”

133 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 133 results

Large-scale testing (Phase 3)Study completedNCT01757405
What this trial is testing

Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen

Who this might be right for
Hemophilia AHemophilia B
Baxalta now part of Shire 40
Testing effectiveness (Phase 2)Study completedNCT02394730
What this trial is testing

Attenuation of D-dimer Using Vorapaxar to Target Inflammatory and Coagulation Endpoints

Who this might be right for
HIV
Kirby Institute 65
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Not applicableStudy completedNCT02911233
What this trial is testing

Evaluation of Clot Stability Induced by Solulin: Evaluation of New Solulin Mutants Lacking Protein C Activation Capacity

Who this might be right for
Hemophilia A
University Hospital, Caen 10
Testing effectiveness (Phase 2)Study completedNCT03407651
What this trial is testing

Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
Catalyst Biosciences 11
Testing effectiveness (Phase 2)Study completedNCT02578706
What this trial is testing

Targeting Platelets in Chronic HIV Infection

Who this might be right for
HIV-1 Infection
Icahn School of Medicine at Mount Sinai 27
Not applicableStudy completedNCT04285840
What this trial is testing

Arterial Versus Venous Activated Clotting Time (ACT) Measurements During Atrial Fibrillation Ablations

Who this might be right for
Atrial Fibrillation
Duke University 40
Not applicableUnknownNCT02785718
What this trial is testing

The Proteins of the Contact Activation System

Who this might be right for
Factor XI DeficiencyFactor XII Deficiency
Hospices Civils de Lyon 18
Not applicableStudy completedNCT00697320
What this trial is testing

Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany

Who this might be right for
Congenital Bleeding DisorderCongenital FVII DeficiencyGlanzmann's Disease+2 more
Novo Nordisk A/S 64
Testing effectiveness (Phase 2)Study completedNCT00508924
What this trial is testing

Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI)

Who this might be right for
Coronary Artery DiseaseAngina, Unstable
Tanabe Pharma Corporation 140
Not applicableStudy completedNCT03051230
What this trial is testing

Vascular Cell Activation, Cell-Derived Microparticles and In Vitro Fertilisation, and In Vitro Fertilisation

Who this might be right for
InfertilityHyperstimulation Syndrome, OvaianThrombosis
Poissy-Saint Germain Hospital 50
Not applicableStudy completedNCT07014722
What this trial is testing

Contact Activation of Coagulation in Newly Inserted Central Venous Catheters

Who this might be right for
Central Venous CatheterCoagulationCoagulation Activation+1 more
Thomas Kander 88
Not applicableUnknownNCT05856903
What this trial is testing

Impact of Emicizumab on Activated Clotting Time Using the i-STAT Alinity Analyzer

Who this might be right for
Hemophilia A
University Hospital, Grenoble 15
Not applicableLooking for participantsNCT02760238
What this trial is testing

Myeloproliferative Neoplasms (MPNs) Patient Registry

Who this might be right for
Primary MyelofibrosisPolycythemia VeraEssential Thrombocythemia+7 more
University Health Network, Toronto 5,000
Not applicableLooking for participantsNCT07313475
What this trial is testing

Evaluation of the Cryocheck HexLA Integrated TCA for the Detection of Lupus Anticoagulant

Who this might be right for
Lupus Anticoagulant
University Hospital, Strasbourg, France 200
Not applicableStudy completedNCT00924859
What this trial is testing

The Role of Factor XIII Activation Peptide and D-dimer Values for the Diagnosis of Cerebral Venous Thrombosis (CVT)

Who this might be right for
Cerebral Venous Thrombosis
Insel Gruppe AG, University Hospital Bern 401
Testing effectiveness (Phase 2)Study completedNCT00823524
What this trial is testing

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Asan Medical Center 47
Post-approval studies (Phase 4)Study completedNCT01812200
What this trial is testing

Antithrombotic Triple Therapy in Humans

Who this might be right for
Atrial FibrillationAcute Coronary Syndrome
Medical University of Vienna 60
Not applicableEnded earlyNCT06257290
What this trial is testing

The Role of Platelet TLRs in Platelet Activation During VTE

Who this might be right for
Venous Thromboembolism
Centre Hospitalier Universitaire de Saint Etienne 44
Early research (Phase 1)Study completedNCT01562457
What this trial is testing

Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 30
Next Page